par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • May 9th, 2018 • Array Biopharma Inc • Pharmaceutical preparations • New York
Contract Type FiledMay 9th, 2018 Company Industry JurisdictionArray BioPharma Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: